News tagged with neutralizing antibodies
Researchers report on the early development of anti-HIV neutralizing antibodies
New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute (Seattle BioMed), Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report ...
Medicine & Health / HIV & AIDS
Jan 14, 2011 |
5 / 5 (1) |
0
|
Designing more effective anti-HIV antibodies
Although people infected with HIV produce many antibodies against the protein encapsulating the virus, most of these antibodies are strangely ineffective at fighting the disease. A new study suggests why some of the most ...
Nov 19, 2010 |
5 / 5 (1) |
1
|
Research on killer HIV antibodies provides promising new ideas for vaccine design
New discoveries about the immune defenses of rare HIV patients who produce antibodies that prevent infection suggest a novel direction for designing new vaccines. Researchers at Rockefeller University and colleagues have ...
Medicine & Health / HIV & AIDS
Sep 29, 2010 |
5 / 5 (4) |
1
|
'New' human adenovirus may not make for good vaccines, after all
In recent years, scientists have studied the possibility of using engineered human adenoviruses as vaccines against diseases such as HIV, tuberculosis, and malaria. In this approach, adenoviruses, which commonly cause respiratory-tract ...
Medicine & Health / HIV & AIDS
Aug 11, 2010 |
5 / 5 (1) |
0
Scientists determine structure of immune molecule that counteracts HIV strains
In findings that contribute to efforts to design an AIDS vaccine, a team led by Scripps Research Institute scientists has determined the structure of an immune system antibody molecule that effectively acts against most strains ...
Medicine & Health / HIV & AIDS
Jun 01, 2010 |
5 / 5 (3) |
0
|
HIV uses several strategies to escape immune pressure
A study of how HIV mutates in response to immune system pressure by Emory Vaccine Center researchers shows that the virus can take several escape routes, not one preferred route.
Medicine & Health / HIV & AIDS
Sep 19, 2009 |
5 / 5 (3) |
0
Study offers insights into failed HIV-1 vaccine trial
Following the disbandment of the STEP trial to test the efficacy of the Merck HIV-1 vaccine candidate in 2007, the leading explanation for why the vaccine was ineffective - and may have even increased susceptibility to acquiring ...
Medicine & Health / HIV & AIDS
Jul 20, 2009 |
5 / 5 (1) |
1
Scientists gain insight into HIV vaccine failure
A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast ...
Medicine & Health / HIV & AIDS
Jul 20, 2009 |
3.5 / 5 (4) |
0
New technology opens gateway to studying HIV-specific neutralizing antibodies
Many scientists believe a vaccine that prevents HIV infection will need to stimulate the body to make neutralizing antibodies, infection-fighting proteins that prevent HIV from entering immune cells. Previous research has ...
Medicine & Health / HIV & AIDS
Mar 16, 2009 |
not rated yet |
0
Scientists Find Rare, Potent Antibody to HIV-1
(PhysOrg.com) -- Scientists at Duke University Medical Center have for the first time isolated an important antibody in human serum that could potentially play a key role in the design of an AIDS vaccine. The research appears ...
Medicine & Health / HIV & AIDS
Feb 23, 2009 |
5 / 5 (4) |
0
- Pages: 1
Neutralizing antibody
A Neutralizing antibody is an antibody which defends a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically. An example of a neutralizing antibody is diphtheria antitoxin, which can neutralize the biological effects of diphtheria toxin.
For more information about Neutralizing antibody, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
